CIK 0000849146
- Accelerated filer
- Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 900224471
- Phone
- +1 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- 4 Grant or award Director acquired 17,185 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 10,477 shares (to pay taxes)
- 4 Grant or award Director acquired 17,185 shares (grant or award)
- 4 Grant or award Director acquired 17,185 shares (grant or award)
- 4 Open-market buy Director bought 18,824 shares at an average $4.74 ($89,166)
- 4 Grant or award President and CEO acquired 276,928 shares (grant or award)
- 4 Shares withheld for taxes Chief Marketing Officer gave up 1,863 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sales Officer gave up 1,546 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 13,011 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 1,621 shares (to pay taxes)
- 4 Exercise or conversion Chief Financial Officer acquired 2,401 shares (option exercise)
- 4 Open-market buy Director bought 4,124 shares at $6.94 ($28,632)
- 4 Open-market buy Director bought 1,000 shares at $7.63 ($7,632)
- 4 Grant or award President and CEO acquired 151,196 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 24,655 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 31,558 shares (grant or award)
- 4 Grant or award Chief Sales Officer acquired 29,586 shares (grant or award)
- 4 Grant or award General Counsel acquired 24,162 shares (grant or award)
- 4 Open-market buy Dayton Judd bought 16,504 shares at an average $4.85 ($80,072)
- 4/A Derivatives Options or other derivatives
Page 8 of 34 · 673 filings